STAAR Surgical PE Ratio 2006-2019 | STAA

Current and historical p/e ratio for STAAR Surgical (STAA) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. STAAR Surgical PE ratio as of February 25, 2020 is 70.77.
STAAR Surgical PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-02-26 28.75 159.72
2019-09-30 25.78 $0.18 143.22
2019-06-30 29.38 $0.16 183.63
2019-03-31 34.19 $0.12 284.92
2018-12-31 31.91 $0.10 319.10
2018-09-30 48.00 $0.08 600.00
2018-06-30 31.00 $0.08 387.50
2018-03-31 14.80 $0.02 740.00
2017-12-31 15.50 $-0.04 0.00
2017-09-30 12.45 $-0.04 0.00
2017-06-30 10.80 $-0.11 0.00
2017-03-31 9.80 $-0.14 0.00
2016-12-31 10.85 $-0.29 0.00
2016-09-30 9.40 $-0.31 0.00
2016-06-30 5.51 $-0.31 0.00
2016-03-31 7.39 $-0.30 0.00
2015-12-31 7.14 $-0.16 0.00
2015-09-30 7.76 $-0.21 0.00
2015-06-30 9.66 $-0.24 0.00
2015-03-31 7.43 $-0.25 0.00
2014-12-31 9.11 $-0.23 0.00
2014-09-30 10.63 $-0.18 0.00
2014-06-30 16.80 $-0.10 0.00
2014-03-31 18.80 $-0.04 0.00
2013-12-31 16.19 $0.01 0.00
2013-09-30 13.54 $-0.01 0.00
2013-06-30 10.15 $-0.02 0.00
2013-03-31 5.63 $-0.04 0.00
2012-12-31 6.10 $-0.04 0.00
2012-09-30 7.56 0 0.00
2012-06-30 7.77 0 0.00
2012-03-31 10.83 $0.03 361.00
2011-12-31 10.49 $0.03 349.67
2011-09-30 7.80 $0.01 780.00
2011-06-30 5.30 $-0.02 0.00
2011-03-31 5.57 $-0.09 0.00
2010-12-31 6.10 $0.00 0.00
2010-09-30 5.41 $-0.25 0.00
2010-06-30 5.72 $-0.28 0.00
2010-03-31 3.82 $-0.27 0.00
2009-12-31 3.10 $-0.43 0.00
2009-09-30 4.08 $-0.48 0.00
2009-06-30 2.41 $-0.50 0.00
2009-03-31 1.00 $-0.55 0.00
2008-12-31 2.38 $-0.79 0.00
2008-09-30 4.49 $-0.62 0.00
2008-06-30 3.10 $-0.67 0.00
2008-03-31 2.58 $-0.74 0.00
2007-12-31 2.64 $-0.58 0.00
2007-09-30 3.00 $-0.65 0.00
2007-06-30 3.82 $-0.63 0.00
2007-03-31 5.51 $-0.60 0.00
2006-12-31 7.01 $-0.60 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.355B $0.124B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.554B 21.10
McKesson (MCK) United States $28.459B 11.16
AmerisourceBergen (ABC) United States $19.133B 12.84
Align Technology (ALGN) United States $18.096B 46.29
Laboratory Of America Holdings (LH) United States $17.916B 16.31
Cooper (COO) United States $16.542B 27.24
Cardinal Health (CAH) United States $16.176B 10.10
Straumann Holding AG (SAUHF) Switzerland $15.439B 0.00
West Pharmaceutical Services (WST) United States $12.004B 50.18
DENTSPLY SIRONA (XRAY) United States $11.454B 22.39
Henry Schein (HSIC) United States $9.052B 17.99
SmileDirectClub (SDC) United States $4.331B 0.00
CONMED (CNMD) United States $2.800B 37.09
Patterson (PDCO) United States $2.240B 16.60
Merit Medical Systems (MMSI) United States $2.204B 27.16
Atrion (ATRI) United States $1.224B 33.72
Antares Pharma (ATRS) United States $0.543B 332.50
Invacare (IVC) United States $0.286B 0.00
Lifevantage (LFVN) United States $0.202B 16.93
Milestone Scientific (MLSS) United States $0.115B 0.00
Pro-Dex (PDEX) United States $0.072B 19.24
Retractable Technologies (RVP) United States $0.053B 81.00
Endologix (ELGX) United States $0.024B 0.00
Biolase (BIOL) United States $0.020B 0.00